Signal: Novo Nordisk’s Wegovy enters new borders

The Danish company's blockbuster Wegovy arrives the UK after the US, Denmark, Norway and Germany amid struggles to meet increasing demands.

Judith Oke September 05 2023

Novo Nordisk’s Wegovy has launched in the UK, as announced by the company in a statement on 4 September. As a result, the Novo Nordisk's shares skyrocketed to as high as 1.9% on Monday (early trading) to a record high of kr1,326 ($192) at a market cap of $421bn.

However, amid the growing demand for Wegovy, the company stated that the drug's availability in the UK will be "controlled and limited" despite attempts to increase production capacity. Reuters recently reported that Novo Nordisk had entered an agreement with Thermo Fisher as its second manufacturer after a series of regulatory breaches by Catalent with the US Food and Drug Administration (FDA).

https://twitter.com/POLITICOEurope/status/1698637238693662884

The Danish pharma’s strategy to control demand is to allocate the drug to people in specialist NHS weight management services who meet the National Institute for Health and Care Excellence (Nice) eligibility criteria (a body mass index of 30 or over and weight-related comorbidities) or privately registered healthcare professionals.

The news follows the research data published in the New England Journal of Medicine, which showed that Wegovy (2.4mg subcutaneous semaglutide) could reduce heart-failure-related symptoms in people with obesity.

https://twitter.com/USATODAY/status/1695124641537277961

Moreover, Eli Lilly’s Mounjaro (tirzepatide) is hot on the heels of Novo Nordisk’s peak position in the obesity landscape. GlobalData forecasts the obesity market to reach $37.1bn across seven major markets, including the US, France, Germany, Italy, Spain, UK and Japan, by 2031.

Our signals coverage is powered by GlobalData’s Thematic Engine, which tags millions of data items across six alternative datasets — patents, jobs, deals, company filings, social media mentions and news — to themes, sectors and companies. These signals enhance our predictive capabilities, helping us to identify the most disruptive threats across each of the sectors we cover and the companies best placed to succeed. 

Uncover your next opportunity with expert reports

Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.

Newsletters by sectors

close

Sign up to the newsletter: In Brief

Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Thank you for subscribing

View all newsletters from across the GlobalData Media network.

close